Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor-Reference-Cited by-同舟云学术

Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor

Published:2012-03 Issue:1-3 Volume:678 Page:78-85
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Ribeiro Alison,Ferraz-de-Paula Viviane,Pinheiro Milena L.,Vitoretti Luana B.,Mariano-Souza Domenica P.,Quinteiro-Filho Wanderley M.,Akamine Adriana T.,Almeida Vinícius I.,Quevedo João,Dal-Pizzol Felipe,Hallak Jaime E.,Zuardi Antônio W.,Crippa José A.,Palermo-Neto João

Funder

FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo

CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Elsevier BV

Subject

Pharmacology

Reference36 articles.

1. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide;Bisogno;Br. J. Pharmacol.,2001

2. Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice;Capasso;Br. J. Pharmacol.,2008

3. Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression;Carrier;Proc. Natl. Acad. Sci. U. S. A.,2006

4. The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors;Castillo;Neurobiol. Dis.,2010

5. Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw;Costa;Naunyn Schmiedebergs Arch. Pharmacol.,2004

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabidiol for treatment of Irritability and Aggressive Behavior in Children and Adolescents with ASD: Background and Methods of the CAnnabidiol Study in Children with Autism Spectrum DisordEr (CASCADE) Study;2024-08-13

2. Potential pharmaceuticals targeting neuroimmune interactions in treating acute lung injury;Clinical and Translational Medicine;2024-08

3. Childhood exposure to cannabidiol and lung function: A pilot study;Pediatric Pulmonology;2024-07-26

4. Unmasking the cannabis paradox: in-hospital outcomes of cannabis users admitted with acute myocardial infarction over a 20-year period in the United States;Archives of Medical Science – Atherosclerotic Diseases;2024-06-22

5. The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders;International Journal of Molecular Sciences;2024-05-25